Search Results - "McKelvy, Jeffrey"

Refine Results
  1. 1
  2. 2
  3. 3

    Targeting HCV entry for development of therapeutics by Wong-Staal, Flossie, Syder, Andrew J, McKelvy, Jeffrey F

    Published in Viruses (01-08-2010)
    “…Recent progress in defining the molecular mechanisms of Hepatitis C Virus (HCV) entry affords the opportunity to exploit new viral and host targets for…”
    Get full text
    Journal Article Book Review
  4. 4

    Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors by Syder, Andrew J, Lee, Haekyung, Zeisel, Mirjam B, Grove, Joe, Soulier, Eric, Macdonald, James, Chow, Stephine, Chang, Julia, Baumert, Thomas F, McKeating, Jane A, McKelvy, Jeffrey, Wong-Staal, Flossie

    Published in Journal of hepatology (01-01-2011)
    “…Background and Aims ITX 5061 is a clinical stage small molecule compound that promotes high-density lipoprotein (HDL) levels in animals and patients by…”
    Get full text
    Journal Article
  5. 5

    Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis C Virus Antivirals by Zhu, Haihong, Wong-Staal, Flossie, Lee, Haekyung, Syder, Andrew, McKelvy, Jeffrey, Schooley, Robert T., Wyles, David L.

    Published in The Journal of infectious diseases (15-02-2012)
    “…ITX 5061 is a scavenger receptor B1 antagonist that has entered phase 1 clinical trials in hepatitis C virus (HCV)-infected humans. We evaluated ITX 5061 in…”
    Get full text
    Journal Article
  6. 6

    Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors by Mittapalli, Gopi Kumar, Jackson, Andrew, Zhao, Fang, Lee, Haekyung, Chow, Stephine, McKelvy, Jeffrey, Wong-Staal, Flossie, Macdonald, James E.

    Published in Bioorganic & medicinal chemistry letters (15-11-2011)
    “…Novel, highly potent small molecule HCV entry inhibitors are reported. The SAR exploration of a hit molecule identified from screening of a compound library…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Discovery of ITX 4520: A highly potent orally bioavailable hepatitis C virus entry inhibitor by Mittapalli, Gopi Kumar, Zhao, Fang, Jackson, Andrew, Gao, Hongfeng, Lee, Haekyung, Chow, Stephine, Kaur, Maninder Pal, Nguyen, Natalie, Zamboni, Robert, McKelvy, Jeffrey, Wong-Staal, Flossie, Macdonald, James E.

    Published in Bioorganic & medicinal chemistry letters (01-08-2012)
    “…The manuscript reports an identification of a highly potent, orally bioavailable hepatitis C virus entry inhibitor through optimization of a previously…”
    Get full text
    Journal Article
  9. 9

    Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis Virus Antivirals by Zhu, Haihong, Wong-Staal, Flossie, Lee, Haekyung, Syder, Andrew, McKelvy, Jeffrey, Schooley, Robert T., Wyles, David L.

    Published in The Journal of infectious diseases (15-02-2012)
    “…ITX 5061 is a scavenger receptor B1 antagonist that has entered phase 1 clinical trials in hepatitis C virus (HCV)-infected humans. We evaluated ITX 5061 in…”
    Get full text
    Journal Article
  10. 10

    ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detection by Hochreiter, Jill, Lapham, Jill, Wong-Staal, Flossie, McKelvy, Jeffrey, Sulkowski, Mark, Glesby, Marshall J, Johnson, Victoria A, Morse, Gene D

    Published in Antiviral therapy (01-01-2013)
    “…ITX 5061 is a highly potent small molecule inhibitor of scavenger receptor-B1, an integral transmembrane protein that is found in liver cells and is actively…”
    Get more information
    Journal Article
  11. 11

    Advances in pain therapeutics by LoGrasso, Philip, McKelvy, Jeffrey

    Published in Current opinion in chemical biology (01-08-2003)
    “…Recent work in defining molecular targets for neuropathic pain has been plentiful and varied. Three novel targets have received much attention recently:…”
    Get full text
    Journal Article
  12. 12

    An aminopeptidase from bovine brain which catalyzes the hydrolysis of enkephalin by Hersh, L B, McKelvy, J F

    Published in Journal of neurochemistry (01-01-1981)
    “…An aminopeptidase from bovine brain which catalyzes the hydrolysis of the tyrosyl1-glycine2 bond of methionine5-enkephalin has been purified to electrophoretic…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Thyrotropin releasing hormone augments growth of spinal cord transplants in oculo by Henschen, A, Zerbe, G, Nadzan, A M, McKelvy, J F, Olson, L, Hoffer, B

    Published in Experimental neurology (01-10-1988)
    “…The effects of thyrotropin releasing hormone (TRH) on spinal cord growth were evaluated using the in oculo transplant model. The growth of fetal spinal cord…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Identification of Aspartic Acid 52 as the Point of Attachment of an Affinity Label in Hen Egg White Lysozyme by Eshdat, Y, McKelvy, J F, Sharon, N

    Published in The Journal of biological chemistry (25-08-1973)
    “…Hen egg white lysozyme, fully inactivated by the affinity-labeling reagent, the 2',3'-epoxypropyl β-glycoside of di-( N -acetyl- d -glucosamine), contained 1…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Two forms of the rat D2 dopamine receptor as revealed by the polymerase chain reaction by Rao, Donald D., McKelvy, Jeffrey, Kebabian, John, MacKenzie, Robert G.

    Published in FEBS letters (09-04-1990)
    “…We have used the polymerase chain reaction technique (PCR) to clone the cDNA of the D2 dopamine receptor from rat striatal mRNA. Two major PCR products were…”
    Get full text
    Journal Article
  20. 20